Scarica l'app Stockscreener
6.82
3.33%
0.22
Dopo l'orario di chiusura:
6.82
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
Forecasting Fulcrum Therapeutics Inc. price range with options dataWeekly Gains Report & Risk Controlled Swing Alerts - Newser
Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN
Measuring Fulcrum Therapeutics Inc.’s beta against major indicesMarket Rally & Weekly Breakout Opportunity Watchlist - Newser
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.July 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Will Fulcrum Therapeutics Inc. Bounce From 52 Week LowTrade Signal Summary & Free Low Drawdown Momentum Trade Ideas - classian.co.kr
XTX Topco Ltd Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World
What makes Fulcrum Therapeutics Inc. stock price move sharplyJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Market Movement Recap & Low Risk Investment Opportunities - Newser
Technical signs of recovery in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Real-Time Market Trend Scan - Newser
Will Fulcrum Therapeutics Inc. rebound enough to break even [2025 Geopolitical Influence]Real-Time Volume Triggers - Newser
Key External Factors That Drive Fulcrum Therapeutics Inc. Stock Price MovementsFree Entry Alert Based on Volume Spikes - Newser
What recovery options are there for Fulcrum Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningBollinger Band Squeeze and Expansion Analysis - Newser
When is the best time to exit Fulcrum Therapeutics Inc.Free ROI Driven Equity Selection With Safety - Newser
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 - MarketScreener
Comparing Fulcrum Therapeutics Inc. in custom built stock radarsSector Rotation Strategy for Smart Traders - Newser
How to interpret RSI for Fulcrum Therapeutics Inc. stockDaily Investment Ideas with Market Insight - Newser
Will Fulcrum Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsSecure Entry Point Finder with Analysis - Newser
How high can Fulcrum Therapeutics Inc. stock goOversold Stock Bounce Playbook Generator - Newser
Why Fulcrum Therapeutics Inc. stock attracts strong analyst attentionWeekly Market Direction and Sector Summary - Newser
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - The Globe and Mail
Is Fulcrum Therapeutics Inc. stock ready for a breakoutLow Volatility Stock Analysis With Confidence - Newser
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen - Defense World
Published on: 2025-08-09 00:54:39 - Newser
Fulcrum Therapeutics Awards $6.96 Stock Options Package: 4-Year Vesting Terms Revealed - Stock Titan
Real time pattern detection on Fulcrum Therapeutics Inc. stockPredicted Market Direction Based on Momentum - Newser
Quant Models Detect Momentum Reversal in Fulcrum Therapeutics Inc.Low Volatility Stable Growth Picks Rank High - beatles.ru
Fulcrum Therapeutics Reports Q2 2025 Financial Results - The Globe and Mail
Technical Bounce Expected in Fulcrum Therapeutics Inc. Next WeekAI Based High Gain Watchlist Scanner Shared - beatles.ru
Strategy Insiders Buy In While Analysts Predict Big Upside - The Globe and Mail
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Buy Alert Based on RSI and Volume - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):